Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

BioHarvest Sciences releases Q3 sales results for Vinia which amounts to 145% year over year growth

BioHarvest Sciences releases Q3 sales results for Vinia which amounts to 145% year over year growth

BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to share news the company’s flagship product Vinia saw a sharp increase in sales in the 3rd Quarter. Sobel sharing with Proactive, VINIA sales orders hit a record high of 1.71 Million dollars which amounts to a 145% increase compared to Q3 2021 and 81% increase compared to Q2 2022. Sales in the United States crossed the 1 million dollar mark. Sobal said guidance still on track for 5-7 in sales orders in 2022, and the company expects to be cash flow positive in 2023.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK